F. Bouchardeau

发表

Expertise of Laboratories in Viral Load Quantification, Genotyping, and Precore Mutant Determination for Hepatitis B Virus in a Multicenter Study

J. Pawlotsky, F. Roudot-thoraval, S. Castelain, 2006, Journal of Clinical Microbiology.

Significance of NS3 and NS5 antigens in screening for HCV antibody

M. Jadoul, C. V. Strihou, Y. Pirson, 1994, The Lancet.

Complete or partial seroreversion in immunocompetent individuals after self‐limited HCV infection: consequences for transfusion

J. Lefrère, R. Girot, S. Laperche, 2004, Transfusion.

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

P. Gallian, P. Morel, S. Laperche, 2005, Journal of Clinical Microbiology.

Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?

M. Deschaseaux, P. Morel, S. Laperche, 2005, Transfusion.

No Evidence of HIV-1 Infection in Seronegative Hemophiliacs and in Seronegative Partners of Seropositive Hemophiliacs through Polymerase Chain Reaction (PCR) and Anti-NEF Serology

P. Rouger, E. Satre, J. Lefrère, 1991, Thrombosis and Haemostasis.

Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.

X. de Lamballerie, P. Marcellin, J. Pawlotsky, 2000, Journal of virological methods.

Detection of hepatitis C virus by polym erase chain reaction in haemodialysed patients in relationship to anti-HCV status.

P. Chauveau, A. Couroucé, A. Girault, 1993, Research in virology.

Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients.

P. Chauveau, A. Couroucé, F. Bouchardeau, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).

P. Chauveau, A. Couroucé, A. Girault, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Analysis of the 5′ Noncoding Region versus the NS5b Region in Genotyping Hepatitis C Virus Isolates from Blood Donors in France

P. Gallian, P. de Micco, S. Laperche, 2006, Journal of Clinical Microbiology.

Hepatitis C Virus: Routes of Infection and Genotypes in a Cohort of Anti-HCV-Positive French Blood Donors

V. Barlet, J. Pillonel, A. Couroucé, 2000, Vox Sanguinis.

Efficacy of HCV core antigen detection during the preseroconversion period

S. Laperche, A. Couroucé, F. Bouchardeau, 2000, Transfusion.

Sensitivity of hepatitis B virus DNA transcription‐mediated amplification testing in hepatitis B surface antigen–positive blood donations

S. Laperche, M. Mercier, A. Girault, 2006, Transfusion.

Determination of hepatitis B virus subtypes by an enzyme immunoassay method using monoclonal antibodies to type‐specific epitopes of HBsAg

S. Laperche, A. Couroucé, A. Girault, 2001, Journal of viral hepatitis.

National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France

S. Laperche, J. Pillonel, M. Mercier, 2010, Transfusion.

HCV RNA in blood donors with isolated reactivities by third‐generation RIBA

V. Barlet, J. Coste, F. Barin, 2000, Transfusion.

A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection

J. Lefrère, S. Laperche, F. Bouchardeau, 2003, Transfusion.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay

P. de Micco, J. Pawlotsky, J. Lefrère, 2007, Journal of Clinical Microbiology.

VIRAEMIA WITH HUMAN PARVOVIRUS

A. Couroucé, F. Bouchardeau, N. Marrec, 1985, The Lancet.

Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors

P. Gallian, P. de Micco, H. Attoui, 2008, Journal of medical virology.

GB Virus type C/HGV markers in HCV RNA‐positive French blood donors: correlation with HCV genotypes and risk factors

S. Laperche, J. Pillonel, A. Couroucé, 2000, Transfusion.

Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.

S. Laperche, A. Couroucé, A. Kolko, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Blood transfusion and human immunodeficiency virus (HIV) antigen.

A. Couroucé, F. Bouchardeau, A. Jullien, 1988, Annals of internal medicine.

HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation

M. Deschaseaux, P. Morel, P. Rouger, 2003, Transfusion.

Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse.

F. Degos, P. Chauveau, A. Couroucé, 1995, Journal of hepatology.

Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits

J. Pawlotsky, G. Duverlie, J. Izopet, 2011, Journal of Clinical Microbiology.

Rapid progression to AIDS in dual HIV-1/HTLV-I infection

E. Wattel, J. Lefrère, A. Couroucé, 1990, The Lancet.

Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load

J. Lefrère, S. Laperche, F. Bouchardeau, 2004, Vox Sanguinis.